Extracorporeal Shockwave Therapy: Difference between revisions
Sue Safadi (talk | contribs) No edit summary |
Sue Safadi (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} | '''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} | ||
</div> | </div> | ||
== | == History of extracorporeal shockwave therapy == | ||
Clinical use of ESWT was first introduced into practice in 1982 for urologic conditions. Subsequent clinical applications in musculoskeletal conditions have been described in treatment of plantar fasciopathy, both upper and lower extremity tendinopathies, greater trochanteric pain syndrome, medial tibial stress syndrome, management of nonunion fractures, and joint disease including avascular necrosis | Clinical use of ESWT was first introduced into practice in 1982 for urologic conditions. Subsequent clinical applications in musculoskeletal conditions have been described in treatment of plantar fasciopathy, both upper and lower extremity tendinopathies, greater trochanteric pain syndrome, medial tibial stress syndrome, management of nonunion fractures, and joint disease including avascular necrosis | ||
== | == Indications for use of ESWT == | ||
Extracorporeal shockwave therapy (ESWT) is primarily used in the treatment of common orthopedic conditions. These include patellar tendinopathy, achilles tendinopathy, medial tibial stress syndrome, plantar fasciopathy and lateral epicondylitis. | Extracorporeal shockwave therapy (ESWT) is primarily used in the treatment of common orthopedic conditions. These include patellar tendinopathy, achilles tendinopathy, medial tibial stress syndrome, plantar fasciopathy and lateral epicondylitis. | ||
Revision as of 03:31, 17 June 2018
Original Editor - Your name will be added here if you created the original content for this page.
Top Contributors - Cindy John-Chu, Sue Safadi, Amanda Ager, Ayushi Tomer, Kim Jackson and Carina Therese Magtibay
History of extracorporeal shockwave therapy[edit | edit source]
Clinical use of ESWT was first introduced into practice in 1982 for urologic conditions. Subsequent clinical applications in musculoskeletal conditions have been described in treatment of plantar fasciopathy, both upper and lower extremity tendinopathies, greater trochanteric pain syndrome, medial tibial stress syndrome, management of nonunion fractures, and joint disease including avascular necrosis
Indications for use of ESWT[edit | edit source]
Extracorporeal shockwave therapy (ESWT) is primarily used in the treatment of common orthopedic conditions. These include patellar tendinopathy, achilles tendinopathy, medial tibial stress syndrome, plantar fasciopathy and lateral epicondylitis.
Clinical Presentation[edit | edit source]
add text here relating to the clinical presentation of the condition, including pre- and post- intervention assessment measures.
Resources[edit | edit source]
add appropriate resources here, including text links or content demonstrating the intervention or technique
